SCHEMBL13048839

SCHEMBL13048839

CC(=O)C(NS(C)(=O)=O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 3/20 0.43
CA12 O43570 2/20 0.43
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
ADAM17 P78536 1/20 0.35
CA2 P00918 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MMP2 P08253 7/20 0.33
MMP13 P45452 7/20 0.33
MMP1 P03956 6/20 0.33
MMP3 P08254 6/20 0.33
MMP9 P14780 6/20 0.33
MMP7 P09237 5/20 0.33
ADAMTS4 O75173 3/20 0.33
TSHR P16473 1/20 0.33
CA1 P00915 1/20 0.33
MMP8 P22894 1/20 0.33
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
MMP14 P50281 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18412644 1.00 CA14 (0.43) CA14CA12CA7CA9ADAM17
SCHEMBL5839741 0.81 KDM4E (0.49) CA14CA12KDM4EMMP2MMP13
SCHEMBL5839738 0.81 KDM4E (0.49) CA14CA12KDM4EMMP2MMP13
SCHEMBL13049836 0.81 CA14 (0.43) CA14CA12CA7CA9ADAM17
SCHEMBL158435 0.79 CA14 (0.42) CA14CA12CA7CA9ADAM17
SCHEMBL1864824 0.79 CA14 (0.42) CA14CA12CA7CA9ADAM17
SCHEMBL1074659 0.79 CA14 (0.42) CA14CA12CA7CA9ADAM17
SCHEMBL6312414 0.79 CA14 (0.42) CA14CA12CA7CA9ADAM17
SCHEMBL17066709 0.77 CA14 (0.41) CA14CA12CA7CA9CA2
SCHEMBL15491572 0.77 CA14 (0.73) CA14CA12CA7CA9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138791-A1 ANTIVIRAL COMPOUNDS COMPOSED OF THREE LINKED ARYL MOIETIES TO TREAT DISEASES SUCH AS HEPATITIS C SCHERING CORPORATION (US) 2010-12-02 WO disclosed